{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:28:09Z","timestamp":1772792889622,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["IMI-2008\/115006"],"award-info":[{"award-number":["IMI-2008\/115006"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0346-8","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T12:02:00Z","timestamp":1473076920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes"],"prefix":"10.1186","volume":"16","author":[{"name":"on behalf of the SUMMIT consortium","sequence":"first","affiliation":[]},{"given":"Isabel","family":"Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"Andreas","family":"Edsfeldt","sequence":"additional","affiliation":[]},{"given":"Helen M.","family":"Colhoun","sequence":"additional","affiliation":[]},{"given":"Angela C.","family":"Shore","sequence":"additional","affiliation":[]},{"given":"Carlo","family":"Palombo","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[]},{"given":"Gunilla Nordin","family":"Fredrikson","sequence":"additional","affiliation":[]},{"given":"Harry","family":"Bj\u00f6rkbacka","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Wigren","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Bengtsson","sequence":"additional","affiliation":[]},{"given":"Gerd","family":"\u00d6stling","sequence":"additional","affiliation":[]},{"given":"Kunihiko","family":"Aizawa","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Casanova","sequence":"additional","affiliation":[]},{"given":"Margaretha","family":"Persson","sequence":"additional","affiliation":[]},{"given":"Kim","family":"Gooding","sequence":"additional","affiliation":[]},{"given":"Phil","family":"Gates","sequence":"additional","affiliation":[]},{"given":"Faisel","family":"Khan","sequence":"additional","affiliation":[]},{"given":"Helen C.","family":"Looker","sequence":"additional","affiliation":[]},{"given":"Fiona","family":"Adams","sequence":"additional","affiliation":[]},{"given":"Jill","family":"Belch","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Pinnola","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Venturi","sequence":"additional","affiliation":[]},{"given":"Michaela","family":"Kozakova","sequence":"additional","affiliation":[]},{"given":"Li-Ming","family":"Gan","sequence":"additional","affiliation":[]},{"given":"Volker","family":"Schnecke","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"issue":"5","key":"346_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00109-014-1146-1","volume":"92","author":"SP Gray","year":"2014","unstructured":"Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications--cardiovascular and kidney disease. J Mol Med. 2014;92(5):441\u201352.","journal-title":"J Mol Med"},{"issue":"12","key":"346_CR2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1463-1326.2008.00898.x","volume":"10","author":"H Abuissa","year":"2008","unstructured":"Abuissa H, O\u2019Keefe Jr J. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection. Diabetes Obes Metab. 2008;10(12):1157\u201366.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"346_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1559-4564.2007.06368.x","volume":"2","author":"MH Schutta","year":"2007","unstructured":"Schutta MH. Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions. J Cardiometab Syndr. 2007;2(2):124\u201330.","journal-title":"J Cardiometab Syndr"},{"issue":"4","key":"346_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/01.HYP.19.4.339","volume":"19","author":"RC Frederich Jr","year":"1992","unstructured":"Frederich Jr RC, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 1992;19(4):339\u201344.","journal-title":"Hypertension"},{"issue":"8","key":"346_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00004872-199917080-00016","volume":"17","author":"K Watanabe","year":"1999","unstructured":"Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H, Miyagawa M, Kohara K. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens. 1999;17(8):1161\u20138.","journal-title":"J Hypertens"},{"issue":"3","key":"346_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1042\/CS20120042","volume":"123","author":"WW Batenburg","year":"2012","unstructured":"Batenburg WW, Danser AH. (Pro)renin and its receptors: pathophysiological implications. Clin Sci (Lond). 2012;123(3):121\u201333.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"346_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Riet Te","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116(6):960\u201375.","journal-title":"Circ Res"},{"issue":"6","key":"346_CR8","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/01.ASN.0000130564.75008.F5","volume":"15","author":"V Esteban","year":"2004","unstructured":"Esteban V, Lorenzo O, Ruperez M, Suzuki Y, Mezzano S, Blanco J, Kretzler M, Sugaya T, Egido J, Ruiz-Ortega M. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol. 2004;15(6):1514\u201329.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"346_CR9","doi-asserted-by":"publisher","first-page":"C1034","DOI":"10.1152\/ajpcell.00432.2007","volume":"294","author":"XC Li","year":"2008","unstructured":"Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-beta1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol. 2008;294(4):C1034\u201345.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"346_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI115881","volume":"90","author":"GH Gibbons","year":"1992","unstructured":"Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90(2):456\u201361.","journal-title":"J Clin Invest"},{"issue":"3","key":"346_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00125-009-1619-x","volume":"53","author":"A Koitka","year":"2010","unstructured":"Koitka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, et al. Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. Diabetologia. 2010;53(3):584\u201392.","journal-title":"Diabetologia"},{"issue":"2","key":"346_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/01.CIR.0000021122.63813.32","volume":"106","author":"R Candido","year":"2002","unstructured":"Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 2002;106(2):246\u201353.","journal-title":"Circulation"},{"issue":"16","key":"346_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685\u201395.","journal-title":"N Engl J Med"},{"key":"346_CR14","doi-asserted-by":"crossref","unstructured":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355(9200):253\u201359.","DOI":"10.1016\/S0140-6736(99)12323-7"},{"issue":"4","key":"346_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2337\/diacare.21.4.597","volume":"21","author":"P Tatti","year":"1998","unstructured":"Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 1998;21(4):597\u2013603.","journal-title":"Diabetes Care"},{"issue":"12","key":"346_CR16","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.2337\/diacare.24.12.2091","volume":"24","author":"L Niskanen","year":"2001","unstructured":"Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A, Group CS. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic\/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. Diabetes Care. 2001;24(12):2091\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"346_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/joim.12359","volume":"278","author":"AC Shore","year":"2015","unstructured":"Shore AC, Colhoun HM, Natali A, Palombo C, Ostling G, Aizawa K, Kennback C, Casanova F, Persson M, Gooding K, et al. Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study. J Intern Med. 2015;278(3):291\u2013302.","journal-title":"J Intern Med"},{"issue":"3","key":"346_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/01.STR.0000058157.69113.F6","volume":"34","author":"I Goncalves","year":"2003","unstructured":"Goncalves I, Moses J, Dias N, Pedro LM, Fernandes e Fernandes J, Nilsson J, Ares MP. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke. 2003;34(3):616\u201322.","journal-title":"Stroke"},{"issue":"9","key":"346_CR19","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/ATVBAHA.114.303414","volume":"34","author":"A Edsfeldt","year":"2014","unstructured":"Edsfeldt A, Goncalves I, Grufman H, Nitulescu M, Duner P, Bengtsson E, Mollet IG, Persson A, Nilsson M, Orho-Melander M, et al. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes. Arterioscler Thromb Vasc Biol. 2014;34(9):2143\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"346_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","volume":"46","author":"H Abuissa","year":"2005","unstructured":"Abuissa H, Jones PG, Marso SP, O\u2019Keefe Jr JH. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 2005;46(5):821\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"1\u20133","key":"346_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","volume":"697","author":"BM Patel","year":"2012","unstructured":"Patel BM, Mehta AA. Aldosterone and angiotensin: role in diabetes and cardiovascular diseases. Eur J Pharmacol. 2012;697(1\u20133):1\u201312.","journal-title":"Eur J Pharmacol"},{"key":"346_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2261-14-148","volume":"14","author":"G Hao","year":"2014","unstructured":"Hao G, Wang Z, Guo R, Chen Z, Wang X, Zhang L, Li W. Effects of ACEI\/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies. BMC Cardiovasc Disord. 2014;14:148.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9590","key":"346_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","volume":"370","author":"A Patel","year":"2007","unstructured":"Patel A, Group AC, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829\u201340.","journal-title":"Lancet"},{"issue":"8","key":"346_CR24","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97(8):1916\u201323.","journal-title":"J Clin Invest"},{"issue":"12","key":"346_CR25","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","volume":"86","author":"M Ruiz-Ortega","year":"2000","unstructured":"Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res. 2000;86(12):1266\u201372.","journal-title":"Circ Res"},{"issue":"12","key":"346_CR26","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","volume":"101","author":"B Schieffer","year":"2000","unstructured":"Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101(12):1372\u20138.","journal-title":"Circulation"},{"issue":"9","key":"346_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/01.RES.83.9.952","volume":"83","author":"XL Chen","year":"1998","unstructured":"Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res. 1998;83(9):952\u20139.","journal-title":"Circ Res"},{"issue":"7","key":"346_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/01.ATV.19.7.1623","volume":"19","author":"R Kranzhofer","year":"1999","unstructured":"Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19(7):1623\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"346_CR29","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/01.CIR.97.17.1731","volume":"97","author":"S Kim","year":"1998","unstructured":"Kim S, Izumi Y, Yano M, Hamaguchi A, Miura K, Yamanaka S, Miyazaki H, Iwao H. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation. 1998;97(17):1731\u20137.","journal-title":"Circulation"},{"issue":"1","key":"346_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00004872-199109010-00003","volume":"9","author":"H Kato","year":"1991","unstructured":"Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9(1):17\u201322.","journal-title":"J Hypertens"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0346-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0346-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:18:33Z","timestamp":1718777913000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0346-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"article-number":"171"}}